Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Androgen Receptor
100%
Epidermal Growth Factor
100%
Co-activation
100%
Recurrent Prostate Cancer
100%
Glucocorticoid Receptor
50%
Receptor-interacting Protein Kinase 1 (RIPK1)
50%
Receptor Transactivation
50%
Transcriptional Intermediary Factor 2
50%
Androgens
25%
Epidermal Growth Factor Signaling
25%
Small Interfering RNA (siRNA)
12%
Post-transcriptional
12%
Site-directed mutagenesis
12%
Prostate
12%
High Affinity
12%
Co-immunoprecipitation (co-IP)
12%
Transcription Factor
12%
Prostate Cancer Cell Lines
12%
Phosphorylation
12%
Prostate Cancer Cells
12%
Coactivator
12%
Ligand-dependent
12%
Androgen-independent
12%
P160
12%
MAPK Inhibitors
12%
TIF2
12%
MiRNA Inhibitors
12%
Neuroscience
Androgen Receptor
100%
Epidermal Growth Factor
100%
Nuclear Receptor Coactivator 2
100%
Transactivation
50%
Androgen
37%
Prostate
37%
extracellular signal regulated kinase
25%
Cell Line
12%
Site-Directed Mutagenesis
12%
Small Interfering RNA
12%
Transcription Factor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Androgen Receptor
100%
Epidermal Growth Factor
100%
Nuclear Receptor Coactivator 2
100%
Androgen
37%
Transcription Factor
12%
Small Interfering RNA
12%
Mutagenesis
12%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
100%
Epidermal Growth Factor
100%
Nuclear Receptor Coactivator 2
100%
Transactivation
50%
extracellular signal regulated kinase
25%
Cancer Cell
25%
Growth Factor Signaling
25%
Site-Directed Mutagenesis
12%
Transcription Factor
12%
Small Interfering RNA
12%